Questionable levels of evidence in new atrial fibrillation guidelines?

Authors :: D. Atar
Paulus Kirchhof
S.H. Hohnloser
R. De Caterina
Gyh Lip
Irene Savelieva
A.J. Camm
G. Hindricks
Source :: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 15(3)
Publication Year :: 2012
Abstract: We read with interest the 2012 focused update of the ESC Guidelines for the management of atrial fibrillation (AF), and more specifically the recommendations formulated for catheter ablation (CA).1 A class I-level of evidence (LoE) A recommendation is attributed to CA for paroxysmal AF in symptomatic drug-refractory patients. In randomized controlled trials (RCTs), AF recurs off-antiarrhythmic drug (AAD) in one-third of patients, 1 year after a single CA.2,3 We have documented that AF recurs in up to 50% after 2 years, which is in line with other observational studies.4,5 The procedure has a …

ISSN :: 15322092
Volume :: 15
Issue :: 3
Database :: OpenAIRE
Journal :: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Accession number :: edsair.doi.dedup.....3b01156b811ea9c7539a85ea51fc39a6

Tools